all the information, none of the junk | biotech • healthcare • life sciences

The Immunex Alumni: Where Are They Now?

(Page 7 of 11)

Susan Marley, senior clinical manager, Novartis

Jenny Martin, manager of clinical operations, GU oncology, University of Washington

Scot Maxon, associate director of medical information, ZymoGenetics

MaryAnne McAdams, director of commercial development, Slate Pharmaceuticals [Added: 6:35 pm, 1/4/11]

Jennifer McCarty, senior manager, research and development informatics, Amgen [Added: 12:25 pm, 1/4/11]

Candice McCoy, principal, Phase Plus Consulting

Teri McCune, clinical research consultant, president, TEMC

Neil McDonnell, deputy director of strategy, global health, Bill & Melinda Gates Foundation

Jeff McGrew, scientific director, Amgen

Peggy McHugh, senior director of clinical operations, IRX Therapeutics

Jim McKibben, retired from Amgen in 2010 [Added: 4:40 pm, 1/4/11]

Karen McLeod, associate director, labeling, ZymoGenetics

Cathy McMahan, director of cell sciences, Trubion Pharmaceuticals (now Emergent Biosolutions)

Kim McNeil, Realtor, Nations Realty [Added: 4:40 pm, 1/4/11]

Cathy McSharry, technical support [Added: 1:15 pm, 1/14/11]

Gary Means, principal scientist, Amgen

Jennifer Mitcham, director of program management, Theraclone Sciences

Thomas Mizelle, biotechnology executive

Ken Mohler, senior vice president of R&D, chief scientific officer, Trubion Pharmaceuticals (now Emergent Biosolutions)

Laura Morgan, associate director, QA, Acucela

Philip Morissey, vice president of biology, Amnis

Jurgen Mullberg, group head and project leader in antibody discovery [Added: 9:20 pm, 1/4/11]

Eileen Murphy, senior program manager, Seattle Biomedical Research Institute [Added: 12:40 pm, 1/6/11]

Suzanne Nelson, senior QA associate, Dendreon

Terry Newcomb, senior director, clinical research, Gilead Sciences

Jennifer Newman, associate director of operations and planning, preclinical R&D, ZymoGenetics

Leslie Nordstrom, QC analyst, BioLife Solutions

Anne Norment, owner, Vista Biotechnology Analysis

Barbara Norwood, quality control supervisor, in vitro biology and microbiology, Dendreon [Added: 8:05 pm, 1/17/11]

Carol Olson, co-chair, Sustainable Path Foundation

Robert Overell, president and CEO, PhaseRx

Mimi Ozaki, clinical regulatory assistant, Trubion Pharmaceuticals (now Emergent Biosolutions)

Cyndi Paluch, reimbursement regional manager, Bayer Healthcare

Dawn Papp, senior executive assistant, Dendreon [Added: 8:05 pm, 1/12/11]

Linda Park, co-chair, Sustainable Path Foundation

Vickie Park, project coordinator, Northwest Hospital … Next Page »

Single Page Currently on Page: 1 2 3 4 5 6 7 8 9 10 11 previous page

By posting a comment, you agree to our terms and conditions.

  • Ajamete Kaykas

    Here are a few more that were forgotten;

    Jurgen Mulberg, Scientist Novartis Vaccine Research

    Pam Smolak, Scientist VLST

    Tom Cox, Scientist Novo Nordisk

    Ajamete Kaykas, Director Allen Institute for Brain Science

  • Thanks Ajamete. I’ve added those people to the list above, and have added the most recent titles I see. I don’t see Mullberg’s new title with Novartis on LinkedIn, and based on her LinkedIn profile, Pam Smolak looks to be no longer with VLST.

    Like I said above in the story, if anyone wants to chime in with more updated titles, please let me know and I’ll make the change.

  • As previous Immunex employee, I hold fond memories and just read an article about my dear old boss, Doug Williams who just accepted a new position as Executive V.P. of Biogen Idec

  • Diane Kolb

    Luke, thanks for the great articles! I too read about Doug Williams and am happy to hear he’s heading back to R&D. So many talents came together under one roof at Immunex. To date, I continue to say that I have had a great career in my chosen path with many wonderful people…but so far, none has come close to the Immunex family.

  • Stephen Cole

    Thanks for this wonderful summary of our Immunex colleagues’ post-Imnx lives. Wonderful.

    Immunex was the start of my career in IT. After completing my MBA post-Amgen acquisition, I have managed in a series of IT organizations, inlcuding EMC, SGI, Commvault and now Symantec.

    I will forever be indebted to Immunex for the opportunity, the environment and the wonderful professionals that I met there.

  • Stephen—thanks for the comment. I can’t help but wonder what you think it was about the culture that made Immunex so special, and how it’s different from many biotech workplaces of today. I’d love to hear from other Immunoids on that one too.

  • I’m an ex-Immunoid. I’m consulting in pathology in San Diego. Baloa BioConsulting, LLC

  • Suzen

    Hi Luke.
    I was with Immunex in Bothell before the “Baby Poster” was released. I did stay with Amgen when we got bought, and moved to the Helix site on the waterfront. Many years have gone by and I have found myself in Denderon with other great collegues. I am the Corp. Facilities Maintenace Planner/Scheduler. Keith LaChappelle is here too. After he left when the “Baby Poster” came out, he struck out on his own and developed the http://www.chimpsanctuarynw.org. He has since come back into the BioTech world and is now my boss as the Corp. Facilities Manager here in Seattle. Small world.
    Hey Immuniods, wanna hook up for a meet up @ Maggies? It’s been so long! I’m also on LinkIN, find me! Happy New Year!

  • Cathy McSharry

    I worked at Immunex from 1996 to 2002 and loved every minute of it. There will never be another Immunex. It was challenging yet rewarding. We were a family who worked together to accomplish the task at hand. I truly loved working at Immunex and miss it greatly. I agree with Diane, so many talents came together under one roof at Immunex.

  • Worked at Immunex from ’91-’94. Truly a dynamic environment composed of a work force with a collectively inspiring attitude. I am honored to have had the opportunity to experience it.

  • breana

    My mom was an immunoid, and she still works for Amgen. I’m doing a project for school on both companies, but I can’t find how many employees they had at any given time. Would somebody please tell me how many immunoids there were by 1982? Thank you very much.
    sincerely, Breana

  • From august to october of 1982, I spent 3 months there as a research consultant, in part because of my frienship w/ Jacques Bertoglio (an INSERM scientist : french équivalenbt of NIH) who worked in Immunex a couple of years. It was the very beginning of Immunex, then localized on one floor of 51, University. My best souvenir ? The TGIF ! Thank’s God It’s Friday.
    Chris and Steven were very kind to me, but I couldn’t accept their proposal because of a national commitment (Service National). Dommage ! What a shame.
    Where are they, and Chris, and Steven, and Larry (Lachman), and etc. I just found Diane Mochizuki on LinkedIn.


    Post-Scriptum : I found the mistake everybody made w/ IL-2. In fact, it’s very simple to make it works. We got a lysis syndrom w/ a multimetastaic lung carcinoma just adding 2 very spécific oligo-elements. Mysterious enough, isn’t it ?